Evidence map›Paper›PMID 41818150›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels.

Sana Ando, Shunta Ikeda, Keiko Tanaka, Yuri Tomabechi, Atsushi Yamagata, Mikako Shirouzu, Ryouichi Tsunedomi, Hiroaki Nagano, Shunya Tsuji, Koichi Sato and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sana AndoLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan.
Shunta IkedaLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan.
Keiko TanakaLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan.
Yuri TomabechiLaboratory for Protein Functional and Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Kanagawa, Japan.ORCID 0000-0001-5208-163X
Atsushi YamagataLaboratory for Protein Functional and Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Kanagawa, Japan.
Mikako ShirouzuLaboratory for Protein Functional and Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Kanagawa, Japan.ORCID 0000-0002-7997-2149
Ryouichi TsunedomiDepartment of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube 755-8505, Yamaguchi, Japan.
Hiroaki NaganoDepartment of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube 755-8505, Yamaguchi, Japan.
Shunya TsujiLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan.ORCID 0009-0004-3169-4647
Koichi SatoLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan.ORCID 0000-0001-5265-0775
Takashi OhamaLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan.ORCID 0000-0003-2998-6689

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 20H03151MEXT | Japan Society for the Promotion of Science (JSPS) 22K19249MEXT | Japan Society for the Promotion of Science (JSPS) 23H02384MEXT | JST | Support for Pioneering Research Initiated by the Next Generation (SPRING) JPMJSP2111
6 · The paper itself

Abstract

The transcription factor c-Myc is a master oncoprotein that regulates over 15% of all genes. Protein phosphatase 2A (PP2A), a crucial tumor suppressor, destabilizes c-Myc protein. Classically, PP2A-mediated dephosphorylation of Ser62 followed by Thr58 phosphorylation was thought to promote ubiquitination of c-Myc by the E3 ligase F-box and WD repeat domain containing 7 (FBXW7). However, recent evidence indicates that FBXW7 preferentially recognizes c-Myc when both Thr58 and Ser62 are phosphorylated, leaving the mechanism underlying PP2A-induced c-Myc degradation unsolved. Here, we demonstrate that the PP2A-B55α complex, which directly dephosphorylates c-Myc at Thr58, regulates two distinct degradation pathways in a biphasic manner: B55α suppression increases Thr58 phosphorylation and enhances FBXW7-dependent degradation, whereas B55α overexpression promotes Thr58-independent, ubiquitin-protein ligase E3 component N-recognin 5 (UBR5)-mediated degradation. We further show that the PP2A-B55α complex binds and dephosphorylates UBR5. In contrast, B55δ, which belongs to the same B55 family and shares a common core structure, exhibits weaker UBR5 binding affinity and fails to induce c-Myc degradation. Our findings identify PP2A-B55α as a context-dependent molecular switch for c-Myc degradation and provide a unified framework that resolves the paradox linking PP2A activation to c-Myc destabilization.

Indexed as

Protein Phosphatase 2ProteolysisProto-Oncogene Proteins c-mycF-Box-WD Repeat-Containing Protein 7HEK293 CellsHumansPhosphorylationUbiquitinationUbiquitin-Protein LigasesF-Box-WD Repeat-Containing Protein 7FBXW7 protein, humanMYC protein, humanPPP2R5A protein, humanProtein Phosphatase 2Proto-Oncogene Proteins c-mycUbiquitin-Protein Ligasesc-MycPPP2R2APPP2R2Dprotein phosphatase 2AUBR5

Identifiers

PMID41818150
PMCPMC12994212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.